Ocular Therapeutix Ownership & Insider Activity

Ocular Therapeutix (OCUL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.7% of shares outstanding. Institutional investors hold 47.0%. Over the past 90 days, insiders made 8 sales worth $568K.

Shares Outstanding

219.616M

Shares Float

186.085M

Insider Shares Owned

8.192M

Insider % Owned

3.7%

Institutional Shares Held

103.224M

Institutional % Held

47.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$568K total

Net Activity

Net Selling

Net Value (90d)

-$568K

Ocular Therapeutix Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 8, 2026	Todd Anderman	CHIEF LEGAL OFFICER	SELL	11.984K	$7.29	$87K
Oct 2, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	9.990K	$7.05	$70K
Oct 2, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	10.869K	$7.05	$77K
Aug 31, 2026	Donald Notman	CHIEF OPERATING OFFICER	SELL	1.099K	$10.24	$11K
Aug 24, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	3.035K	$10.77	$33K
Aug 24, 2026	Sanjay Nayak	CHIEF STRATEGY OFFICER	SELL	1.897K	$10.78	$20K
Aug 24, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	3.296K	$10.78	$36K
Aug 24, 2026	Pravin Dugel	SEE REMARKS	SELL	21.649K	$10.77	$233K
Jun 3, 2026	Nadia Waheed	CHIEF MEDICAL OFFICER	SELL	14.828K	$8.27	$123K
May 26, 2026	Pravin Dugel	SEE REMARKS	SELL	21.156K	$8.20	$173K
May 26, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	2.967K	$8.20	$24K
May 26, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	3.018K	$8.20	$25K
May 26, 2026	Sanjay Nayak	CHIEF STRATEGY OFFICER	SELL	1.858K	$8.20	$15K